bendamustine hydrochloride has been researched along with vorinostat in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, H | 1 |
| Ogura, M | 1 |
| Alsina, M; Anderson, KC; Bensinger, W; Biermann, JS; Cohen, AD; Devine, S; Djulbegovic, B; Faber, EA; Gasparetto, C; Hernandez-Illizaliturri, F; Huff, CA; Kassim, A; Krishnan, AY; Kumar, R; Liedtke, M; Meredith, R; Raje, N; Schriber, J; Shead, DA; Singhal, S; Somlo, G; Stockerl-Goldstein, K; Treon, SP; Weber, D; Yahalom, J; Yunus, F | 1 |
| Chen, Y; Mehrling, T | 1 |
| Bellosillo, B; Besses, C; Camacho, L; Fernández-Rodríguez, C; Ferraro, M; Gimeno, E; Navarro, A; Pairet, S; Salar, A; Sanchez-Gonzalez, B; Serrano, S | 1 |
| Chen, Y; Colapietro, A; Cristiano, L; Delle Monache, S; Festuccia, C; Gravina, GL; Mancini, A; Marampon, F; Mehrling, T; Pompili, S; Tombolini, V; Vetuschi, A; Vitale, F | 1 |
| Guo, W; Huang, J; Huang, S; Huang, X; Jin, J; Li, F; Li, X; Ling, Q; Pan, J; Ye, W | 1 |
| Chen, P; Gan, Y; Gao, F; He, X; Li, S; Lin, L; Qian, W; Qiu, X; Tong, J; Xu, Y; Yu, T; Zhang, J; Zhang, X | 1 |
1 review(s) available for bendamustine hydrochloride and vorinostat
| Article | Year |
|---|---|
[Development of novel agents for multiple myeloma; now and the future].
Topics: Animals; Antibodies, Monoclonal, Humanized; Bendamustine Hydrochloride; Benzoquinones; Benzylamines; Clinical Trials as Topic; Cyclams; Drug Discovery; Drug Therapy, Combination; Heterocyclic Compounds; Humans; Hydroxamic Acids; Lactams, Macrocyclic; Molecular Targeted Therapy; Multiple Myeloma; Nitrogen Mustard Compounds; Oligopeptides; Thalidomide; Vorinostat | 2011 |
1 trial(s) available for bendamustine hydrochloride and vorinostat
| Article | Year |
|---|---|
[Current development of new drugs in malignant lymphoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Brentuximab Vedotin; Diphtheria Toxin; Drug Discovery; Everolimus; Humans; Hydroxamic Acids; Immunoconjugates; Indoles; Inotuzumab Ozogamicin; Interleukin-2; Lenalidomide; Lymphoma; Lymphoma, B-Cell; Nitrogen Mustard Compounds; Purine Nucleosides; Pyrazines; Pyrimidinones; Recombinant Fusion Proteins; Sirolimus; Thalidomide; Vorinostat | 2012 |
6 other study(ies) available for bendamustine hydrochloride and vorinostat
| Article | Year |
|---|---|
Multiple myeloma, version 1.2013.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Dexamethasone; Disease Progression; Humans; Hydroxamic Acids; Lenalidomide; Multiple Myeloma; Nitrogen Mustard Compounds; Oligopeptides; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Pyrazines; Recurrence; Salvage Therapy; Thalidomide; Vorinostat | 2013 |
The Alkylating-HDAC Inhibition Fusion Principle: Taking Chemotherapy to the Next Level with the First in Class Molecule EDO-S101.
Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Benzimidazoles; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured; Vorinostat | 2016 |
Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells.
Topics: Acetylation; Antineoplastic Agents; Apoptosis; Bendamustine Hydrochloride; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; DNA Breaks, Double-Stranded; Gene Expression; Genes, p53; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Lymphoma, Large B-Cell, Diffuse; Vorinostat | 2016 |
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Benzimidazoles; Brain Neoplasms; Cell Line, Tumor; Female; Glioblastoma; Histone Deacetylase Inhibitors; Humans; Mice; Vorinostat | 2018 |
Novel SAHA‑bendamustine hybrid NL‑101 in combination with daunorubicin synergistically suppresses acute myeloid leukemia.
Topics: Animals; Bendamustine Hydrochloride; Cell Line, Tumor; Cell Proliferation; Cell Survival; Daunorubicin; DNA Damage; Drug Synergism; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice; Vorinostat; Xenograft Model Antitumor Assays | 2020 |
Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Bendamustine Hydrochloride; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Feedback, Physiological; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, B-Cell; Mice; Mice, Inbred NOD; MicroRNAs; Molecular Targeted Therapy; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-myc; Repressor Proteins; Signal Transduction; Survival Analysis; Tumor Burden; Vorinostat; Xenograft Model Antitumor Assays | 2021 |